-
-
Call more information
660-596-2224 -
SmartTots Releases Updated Consensus Statement Regarding Anesthesia Safety in Young Children Health experts say growing evidence points to need for more research; urge caution but not alarm San Francisco, CA (October 13, 2015) SmartTots today released an updated consensus statement that emphasizes a need for more research into the safety of anesthetics and sedatives administered to infants and […]
Read MoreIn patients with low back pain, early physical therapy does not lead to clinically meaningful improvements in disability or pain, a JAMA study finds. The study included some 200 adults seen in primary care with low back pain of less than 16 days’ duration, with a disability score of 20 or higher (on a 100-point scale), and […]
Read MoreAuthors: Susan Curling, M.D., M.B.A. ASA Monitor 10 2015, Vol.79, 18-19. Susan Curling, M.D., M.B.A., is former Medical Director for Quality, Memorial Hermann Hospital Northeast, Humble, Texas. The core goal of leadership is to develop an inspired culture that changes a job into a calling. Several physician anesthesiologists have been instrumental in accomplishing this goal. In a […]
Read MoreAuthors: Nicholas M. Halzack, M.P.H. et al ASA Monitor 10 2015, Vol.79, 10-12. The relationship between surgical volume and patient outcomes has been studied extensively since the 1980s. The “volume” variable is often measured in two ways: hospital volume (the amount of surgeries the hospital performs) and surgeon volume (the amount of surgeries each surgeon performs). So, […]
Read MoreThe US Food and Drug Administration (FDA) has granted accelerated approval to Praxbind (idarucizumab, Boehringer Ingelheim) to rapidly reverse the blood-thinning effects of the anticoagulant Pradaxa (dabigatran, Boehringer Ingelheim). “The anticoagulant effects of Pradaxa are important and life-saving for some patients, but there are situations where reversal of the drug’s effects is medically necessary,” said […]
Read More